XTRN news from yesterday.
I've got a small pile about .23
Xtrana Announces Exclusive Distribution Agreement With Marsh Bio Products
Wednesday August 28, 4:37 pm ET
BROOMFIELD, Colo.--(BUSINESS WIRE)--Aug. 28, 2002--Xtrana, Inc. (OTCBB:XTRN - News) today announced that it has entered into a multi-year exclusive distribution agreement with Marsh Bio Products, Inc. (an ABgene Company), Rochester, NY, to market and sell Xtrana's Xtra Amp(TM) Nucleic Acid Extraction Kits in the United States.
ADVERTISEMENT
The Xtra Amp product line offers a novel, sensitive and reproducible approach to nucleic acid purification. Based on a proprietary solid phase matrix called Xtra Bind(TM), nucleic acid is bound to the surface of the Xtra Bind material which is coated on the inside of traditional PCR tubes or the wells of microtiter plates. Since the entire protocol is performed in a single tube, there is reduced risk of cross contamination, and reduced cost. The protocol is also limited to fluid handling steps that typically require only 3 minutes of user interaction, and there is no need for vacuum filtration, centrifugation, elution, sample transfer, or hazardous chemicals such as phenol. Nucleic acid is highly stable when bound to the Xtra Bind matrix, and can be stored at room temperature for extended periods rather than using valuable freezer space.
Tim Dahltorp, Xtrana's CEO, states: "We are very pleased to enter into this partnership with Marsh. This agreement will provide Xtrana access to a strong and technically capable sales force in the United States, which is the largest single market in the world for nucleic acid purification products. Additionally, Marsh is an ideal partner as their current product lines are complementary to Xtra Amp."
Jim Marsh, President of Marsh Bio Products, Inc., added: "Our goal is to continue to bring exciting and unique products to market. Xtra Amp gives us another new and innovative product to offer our customers and will enhance our current offering of PCR consumables and reagents."
Xtrana, Inc. develops, manufactures and markets novel nucleic acid extraction kits and detection systems for use in molecular diagnostics, drug discovery, forensics, research, clinical and life sciences markets. To learn more about Xtrana, visit the Company's web site at www.xtrana.com.
Marsh Bio Products, Inc. (an ABgene company) is a global provider of laboratory consumables, reagents, and instrumentation to biotech, pharmaceutical and academic research laboratories. For more information, or to place an order, call 800-445-2812 or visit www.marshbio.com.
This press release contains forward-looking statements (identified by the words "estimate," "anticipate," "expect," believe," and similar expressions) which are based upon the management's current expectations and speak only as of the date made. These forward-looking statements are subject to risks, uncertainties and factors that could cause actual results to differ materially from the results anticipated in the forward-looking statements and include, but are not limited to, competitors' pricing strategies and technological innovations, changes in health care and government regulations, litigation claims, foreign currency fluctuation, product acceptance, as well as other factors discussed in the Company's last Report on Form 10-KSB.
--------------------------------------------------------------------------------
Contact:
Xtrana, Inc.
Timothy Dahltorp, 303/466-4424 |
